Why Are Johnston Press plc, Victoria PLC & Judges Scientific PLC Rising Today?

Roland Head takes a look at three of today’s top small-cap risers, Johnston Press plc (LON:JPR) Victoria PLC (LON:VCP) Judges Scientific PLC (LON:JDG).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Structural decline

One of today’s biggest risers is local newspaper group Johnston Press (LSE: JPR), whose shares are up by 17%.

The group’s adjusted pre-tax profit rose by 22% to £31.5m last year, while net debt fell by £14.8m to £179.4m.

The planned acquisition of the i national daily newspaper for £24m has been approved and will go ahead soon. Johnston says that the i deal will give the group access to a 20% share of the “quality market” and will increase earnings and improve cash generation.

However, the structural decline of the group’s business continued last year. Total revenue from continuing businesses fell by 6.8% to £242.3m. Operating profit fell by 7.5% to £50.6m.

The increase in adjusted pre-tax profits I mentioned earlier was mainly the result of lower finance costs, not improved trading.

Johnston Press currently trades on a 2016 forecast P/E of 2. This sounds cheap, but with sales falling and net debt running at 16 times trailing profits, I think the shares are too risky. I’d stay away.

Too late

Carpet manufacturer and retailer Victoria (LSE: VCP) climbed by nearly 9% this morning to a 52-week high of 1,519p. The group said that full-year profits for the year ending 2 April are expected to be “materially ahead” of current forecasts.

In my view this suggests an increase of at least 10% on current forecasts, suggesting adjusted earnings per share of around 80p. The group says that an increased focus on cash generation will also result in a fall in net debt. This is good news, as net debt has risen sharply over the last two years.

Despite this, I do have some reservations about Victoria. The shares currently trade on around 19 times 2016 forecast profits, and offer no yield. This seems quite a full valuation, to me.

A second concern is that companies which grow through a series of rapid acquisitions often end up coming unstuck. I’d like to see more evidence of sustainable profit growth and free cash flow before taking a more positive view.

In my view, it’s probably too late to buy into Victoria.

Strong outlook

Judges Scientific (LSE: JDG) is also an acquisitive business, but unlike Victoria has a long track record of success. Judges’ business model is based on adding small specialist businesses to its portfolio of companies which produce scientific instruments.

The shares are up modestly after today’s solid set of results. Revenue rose by 38.5%, thanks to last year’s acquisition of Armfield. Adjusted earnings per share were 32% higher, at 109.2p. There was some organic growth too — sales excluding Armfield rose by 4.9%.

Shareholders have been rewarded with a 13.6% dividend hike. This takes the total payout to 25p per share, giving a 1.5% trailing yield.

The outlook for 2016 appears strong. Judges said this morning that the group ended 2015 with an order book covering 11.9 weeks, up from 9.9 weeks at the end of 2014. The balance sheet also seems safe, with net debt of only £4.4m — much less than last year’s net profit of £7m.

Is Judges Scientific a buy? In my view it’s a good firm, but the 2016 forecast P/E of 16 suggests that upside may be limited. I’d hold for now.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Roland Head has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »